TetraLogic Pharmaceuticals Corporation
TLOG
$0.00
$0.000.00%
OTC PK
| 09/30/2016 | 06/30/2016 | 03/31/2016 | 12/31/2015 | 09/30/2015 | |
|---|---|---|---|---|---|
| Net Income | -27.98% | 39.03% | 22.47% | -30.98% | 8.23% |
| Total Depreciation and Amortization | -56.54% | -70.84% | 51.97% | 0.21% | 1.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 91.34% | -11.02% | -43.32% | 76.34% | 58.68% |
| Change in Net Operating Assets | 158.84% | -179.08% | 28,450.00% | -97.70% | 142.68% |
| Cash from Operations | 52.33% | 2.81% | 34.39% | -19.73% | 28.80% |
| Capital Expenditure | -- | -- | -- | 97.33% | -63.75% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -40.04% | -2.34% | 37.58% |
| Cash from Investing | -- | -100.00% | -38.25% | -2.05% | 37.51% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | 258,450.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -100.00% | 258,450.00% |
| Foreign Exchange rate Adjustments | 217.14% | -133.02% | -84.25% | 150.60% | -77.81% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 52.43% | -671.12% | -25.24% | -117.50% | 176.60% |